WebJul 20, 2024 · Axumin is supplied as a clear, colorless injection in a 30 mL or 50 mL multiple-dose glass vial containing approximately 26 mL solution of 335 MBq/mL to 8,200 MBq/mL (9 mCi/mL to 221 mCi/mL) fluciclovine F 18 at calibration time and date. 30 mL sterile multiple-dose vial: NDC 69932-001-30 50 mL sterile multiple-dose vial: NDC … Webdevelopmental outcomes in pregnant women or animals with the use of piflufolastat F 18. All radiopharmaceuticals, including PYLARIFY, have the potential to cause fetal harm …
Fluciclovine (18F) - Wikipedia
WebDec 14, 2024 · To investigate the utility of fluciclovine F 18 for evaluation for metastatic disease in men undergoing laser focal therapy of prostate cancer and the impact on inclusion for a focal therapy cohort. ... DMI Axumin-001 Protocol. No: 20241334 ( Other Identifier: Western IRB (WIRB) ) Study No: 1176339 ( Other Identifier: Western IRB … WebFULL PRESCRIBING INFORMATION 1 INDICATIONS AND USAGE NETSPOT, after radiolabeling with Ga 68, is indicated for use with positron emission tomography (PET) for russ howerton
Axumin (Blue Earth Diagnostics): FDA Package Insert
WebCardinal Health FDA Approved Radiopharmaceuticals WebDec 19, 2024 · Axumin is a diagnostic medicine used with a body scan to check whether or not prostate cancer has returned. It is used specifically with the body scan known as positron-emission tomography (PET) in men whose blood test for prostate-specific antigen (PSA) indicate that the cancer may have returned. Axumin is a ‘radiopharmaceutical’: it ... WebMar 5, 2024 · Axumin is available in a 30 mL multiple-dose glass vial containing clear, colorless solution of 335-8200 MBq/mL (9-221mCi/mL) fluciclovine F 18 at calibration time and date. Axumin is a radioactive diagnostic agent indicated for positron emission tomography (PET) imaging in men with suspected prostate cancer recurrence based on … russ hulbert shelton wa